CB Insights
Technology Market Intelligence
Technology Market Intelligence
Public list: Medical Devices (6162)
ReVascular Therapeutics has pioneered advances in technology for the intravascular treatment of complex lesions and total occlusions that typically cannot be treated using current catheter-based technologies and products.
Company (Alive / Active)
Phone: 408-617-0770
766 Palomar Ave
Sunnyvale, 94085
California, United States
| Total Funding | Date of Last Funding | |
|---|---|---|
| Revascular Therapeutics | $7.3M | Aug 14, 2009 |
| ALung Technologies | $125.9M | Aug 14, 2019 |
| Aradigm Corporation | $152.7M | Dec 23, 2004 |
| See all 16 competitors | ||
| Per Week | Per Month | Per 6 Months | Per Year | |
|---|---|---|---|---|
| Rank | Login to see details | |||
| Page Views Per Million | Login to see details | |||
| Page Views Per User | Login to see details | |||
| Reach Per Million | Login to see details | |||
| Investor | Investor Type | Location | Participating Rounds |
|---|
| Title | Application Date | Patent Date | Status (Patent / Application) |
|---|---|---|---|
| Method and system for reversibly controlled drilling of luminal occlusions | Jan 10, 2014 | Nov 21, 2017 | Patent |
| Guidewire for crossing occlusions or stenoses having a shapeable distal end | Aug 31, 2007 | Feb 09, 2016 | Patent |
| Guidewire for crossing occlusions or stenoses | Feb 26, 2014 | Aug 25, 2015 | Patent |
| Delivery and exchange catheter for storing guidewire | Apr 23, 2012 | Aug 12, 2014 | Patent |
| Guidewire for crossing occlusions or stenoses | Jul 18, 2013 | Jun 10, 2014 | Patent |
